Concurrent COVID-19 in acute myocardial infarction patients was associated with higher in-hospital mortality compared to non-COVID-19 cases (aOR 3.19; 95% CI 2.63-3.88).
Observational
Yes
Does concurrent COVID-19 infection and race/ethnicity impact in-hospital mortality and management in patients with acute myocardial infarction?
Concurrent COVID-19 infection in AMI patients is associated with significantly higher in-hospital mortality and complications, with pronounced racial disparities in outcomes and access to procedures like PCI and CABG.
Effect estimate: aOR 3.19 (95% CI 2.63-3.88)
This study assessed the COVID-19 pandemic's impact on racial disparities in acute myocardial infarction (AMI) management and outcomes. We reviewed AMI patient management and outcomes in the pandemic's initial nine months, comparing COVID-19 and non-COVID-19 cases using 2020's National Inpatient Sample data. Our findings revealed that patients with concurrent AMI and COVID-19 had higher in-hospital mortality (aOR 3.19, 95% CI 2.63-3.88), increased mechanical ventilation (aOR 1.90, 95% CI 1.54-2.33), and higher initiation of hemodialysis (aOR 1.38, 95% CI 1.05-1.89) compared to those without COVID-19. Moreover, Black and Asian/Pacific Islander patients had higher in-hospital mortality than White patients, (aOR 2.13, 95% CI 1.35-3.59; aOR 3.41, 95% CI 1.5-8.37). Also, Black, Hispanic, and Asian/Pacific Islander patients showed higher odds of initiating hemodialysis (aOR 5.48, 95% CI 2.13-14.1; aOR 2.99, 95% CI 1.13-7.97; aOR 7.84, 95% CI 1.55-39.5), and were less likely to receive PCI for AMI (aOR 0.71, 95% CI 0.67-0.74; aOR 0.81, 95% CI 0.77-0.86; aOR 0.82, 95% CI 0.75-0.90). Black patients also showed less likelihood of undergoing CABG (aOR 0.55, 95% CI 0.49-0.61). Our study highlights elevated mortality and complications in COVID-19 AMI patients, emphasizing significant racial disparities. These findings underscore the pressing need for initiatives addressing healthcare disparities, enhancing access, and promoting culturally sensitive care to boost health equity.
Muhyieddeen et al. (Thu,) conducted a observational in Acute myocardial infarction and COVID-19. Concurrent COVID-19 vs. Without COVID-19 was evaluated on In-hospital mortality (aOR 3.19, 95% CI 2.63-3.88). Concurrent COVID-19 in acute myocardial infarction patients was associated with higher in-hospital mortality compared to non-COVID-19 cases (aOR 3.19; 95% CI 2.63-3.88).